These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 31526257)
1. Bone Marrow and Tumor Radiomics at Mattonen SA; Davidzon GA; Benson J; Leung ANC; Vasanawala M; Horng G; Shrager JB; Napel S; Nair VS Radiology; 2019 Nov; 293(2):451-459. PubMed ID: 31526257 [TBL] [Abstract][Full Text] [Related]
2. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer. Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452 [TBL] [Abstract][Full Text] [Related]
3. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Wu J; Aguilera T; Shultz D; Gudur M; Rubin DL; Loo BW; Diehn M; Li R Radiology; 2016 Oct; 281(1):270-8. PubMed ID: 27046074 [TBL] [Abstract][Full Text] [Related]
4. [ Yang M; Li X; Cai C; Liu C; Ma M; Qu W; Zhong S; Zheng E; Zhu H; Jin F; Shi H Eur Radiol; 2024 Jul; 34(7):4352-4363. PubMed ID: 38127071 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection. Lee JW; Na JO; Kang DY; Lee SY; Lee SM Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer. Prévost S; Boucher L; Larivée P; Boileau R; Bénard F J Nucl Med; 2006 Apr; 47(4):559-65. PubMed ID: 16595487 [TBL] [Abstract][Full Text] [Related]
7. Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer. Mostafa R; Abdelsamie Kandeel A; Abd Elkareem M; Nardo L; Abdelhafez YG Nucl Med Commun; 2022 May; 43(5):540-548. PubMed ID: 35190518 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351 [TBL] [Abstract][Full Text] [Related]
9. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study. Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Computed Tomography and/or Moran A; Wang Y; Dyer BA; Yip SSF; Daly ME; Yamamoto T Clin Lung Cancer; 2021 Sep; 22(5):461-468. PubMed ID: 33931316 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in tumours: Validating the use of radiomic features on Krarup MMK; Nygård L; Vogelius IR; Andersen FL; Cook G; Goh V; Fischer BM Radiother Oncol; 2020 Mar; 144():72-78. PubMed ID: 31733491 [TBL] [Abstract][Full Text] [Related]
15. Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253 [No Abstract] [Full Text] [Related]
16. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
17. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and Ju H; Kim K; Kim BI; Woo SK Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770 [TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram combining Zhang Y; Cui Y; Liu H; Chang C; Yin Y; Wang R Sci Rep; 2024 Sep; 14(1):20557. PubMed ID: 39231973 [TBL] [Abstract][Full Text] [Related]
19. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial. Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281 [TBL] [Abstract][Full Text] [Related]
20. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]